IA
BIB icon

IFP Advisors’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

IFP Advisors’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-500
Closed -$29K – 3825
2018
Q2 		$29K Buy
+500
New +$27.3K ﹤0.01% 2241
2017
Q3 		– Sell
-1,600
Closed -$85K – 4071
2017
Q2 		$85K Buy
+1,600
New +$78.1K ﹤0.01% 1622

Other funds holding BIB

IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

IFP Advisors's BIB Position: Q1 2023 in Review

IFP Advisors sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q1 2023, closing a stake of 150 shares — an estimated $9K sold.

IFP Advisors first reported a position in BIB in Q2 2017 and held it in 13 quarters. The position peaked at $53K in Q2 2017. 24 funds tracked by Wall St. Rank hold BIB as of Q1 2023.

  • IFP Advisors reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q1 2023 after selling out during the quarter.
  • IFP Advisors sold 150 ProShares Ultra NASDAQ Biotechnology shares in Q1 2023, an estimated $9K.
  • IFP Advisors first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2017 and held it in 13 quarters.
  • IFP Advisors's ProShares Ultra NASDAQ Biotechnology position peaked at $53K in Q2 2017.
  • 24 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q1 2023.

Based on IFP Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.